Sotera Health
SHC· Services· Fiscal year ends in December
Michael B. Petras, Jr. is the CEO of Sotera Health and was paid $10.7M in FY2025 (Dec), up 3%.
Executives4
See all- 1Michael B. Petras, Jr.Chairman and CEOFY2025
- 2Jonathan LyonsSVP, CFOFY2025
- 3Alex DimitriefFormer SVP and General CounselFY2025
- 4Michael P. RutzPresident of SterigenicsFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allSotera Health paid its 4 named executives $18.4M in total in FY2025 (Dec). CEO Michael B. Petras, Jr. was paid $10.7M of that.
| Name | |||
|---|---|---|---|
| Michael B. Petras, Jr.Chairman and CEO | |||
| Jonathan LyonsSVP, CFO | |||
| Alex DimitriefFormer SVP and General Counsel | |||
| Michael P. RutzPresident of Sterigenics |
of each named executive, from the Summary Compensation Table of each proxy.
Peers19
See allThe FY2024 (Dec) proxy of Sotera Health names 19 peer companies for pay. Among Sotera Health and these peers, CEO pay was 4th highest of 12 and total shareholder return was 11th highest of 12.
4th highest of 12in Sotera Health and its pay peers, FY2024 (Dec) by CEO pay:
11th highest of 12in Sotera Health and its pay peers, FY2024 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board4
See all- Vincent K. PetrellaLead independent director · 5 yr on the boardIndependentAudit (Chair)—Paid as an executive
- James C. NearyDirector · 10 yr on the boardIndependent—Paid as an executive
- Karen A. FlynnDirector · 2 yr on the boardIndependentAudit—Paid as an executive
- Kenneth D. KrauseDirector · -1 yr on the boardIndependentAudit—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 8, 2026 | FY2025 |
| Annual report | 10-K | Feb 24, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 10, 2025 | FY2024 |
| Annual report | 10-K | Feb 27, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 11, 2024 | FY2023 |
| Annual report | 10-K | Feb 27, 2024 | FY2023 |